Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Issued: 2012-2025

Historic Shares Issued for Agios Pharmaceuticals (AGIO) over the last 11 years, with Sep 2025 value amounting to $4.4 million.

  • Agios Pharmaceuticals' Shares Issued rose 68.18% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 4.92%. This contributed to the annual value of $14.4 million for FY2024, which is 165.82% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Shares Issued stood at $4.4 million for Q3 2025, which was up 6,723.08% from $65,000 recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Shares Issued ranged from a high of $25.7 million in Q2 2021 and a low of $16,000 during Q2 2022.
  • Over the past 3 years, Agios Pharmaceuticals' median Shares Issued value was $1.9 million (recorded in 2023), while the average stood at $2.4 million.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Shares Issued skyrocketed by 1,454.06% in 2021, and later tumbled by 99.94% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Shares Issued (Quarterly) stood at $267,000 in 2021, then crashed by 60.67% to $105,000 in 2022, then spiked by 706.67% to $847,000 in 2023, then soared by 471.66% to $4.8 million in 2024, then spiked by 68.18% to $4.4 million in 2025.
  • Its Shares Issued was $4.4 million in Q3 2025, compared to $65,000 in Q2 2025 and $1.6 million in Q1 2025.